Back to search

Article

Preventing pathogenic dimerization in a misfolded antibody light chain through the design of an inhibitory peptide

2025-09-20

Abstract excerpt

Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. The disease correlates with the formation of insoluble aggregates mostly composed by patient-specific antibody light chains, whose hypervariable regions make each case unique and highlight the need for personalized therapeutics. In this study, we focused on a pathogenic homodimer we previously obtained from a patient-deriv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d810514-c049-58ce-9653-9fe2597a7af0
DOI
10.1101/2025.09.16.676588
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preventing pathogenic dimerization in a misfolded antibody light chain through the design of an inhibitory peptideDOI 10.1101/2025.09.16.676588
Select a neighboring publication to make it the new centre.